|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
Pharmaceutical M&A in the Asia-Pacific Region - India and China drive regional activity but Japan still dominates high value transactions Price: $7,600.00 (€5,950.56) ($9,120.00 (€7,140.68) Including VAT at 20%)
|
| Publication Date: 19-Aug-2010 Please click here for more information or to purchase this report at our partner store
An overview of merger and acquisition (M&A) trends in developed and emerging pharmaceutical markets in the Asia-Pacific region from Q1 2007 to Q1 2010, with discussion of the drivers of recent deals and analysis of key M&As in individual countries. |
|
 |
|
 |
|
 |
Building Biotech Technology Transfer Opportunities: Sponsor and developer strategies for success Price: $3,835.00 (€3,002.69) ($4,602.00 (€3,603.22) Including VAT at 20%)
|
| Publication Date: 01-Feb-2010 Please click here for more information or to purchase this report at our partner store
Biotech tech transfer project failures could often be averted, as many of the most common reasons for failure are preventable problems relating to due diligence failures, shortcomings in deal structure, management changes, cultural challenges, and inappropriate project organization and expectations. This report provides details on how to avoid these common pitfalls with case studies that illustrate best practice. |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |